Safety and Immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic stem cell transplantation (alloHCT)

Due to the morbidity and mortality of meningococcal disease, the Advisory Committee of Immunization Practices recommended in 2007 immunization of all children 11–18 years old with a protein-conjugated meningococcal vaccine. There is limited data on the immunogenicity of this vaccine following alloHC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mahler, Michelle B., Taur, Ying, Jean, Raymond, Kernan, Nancy A, Prockop, Susan E, Small, Trudy N.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286795/
https://ncbi.nlm.nih.gov/pubmed/21820392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2011.07.027
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge